Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving01:29

Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving

Mechanistic models play a crucial role in algorithms for numerical problem-solving, particularly in nonlinear mixed effects modeling (NMEM). These models aim to minimize specific objective functions by evaluating various parameter estimates, leading to the development of systematic algorithms. In some cases, linearization techniques approximate the model using linear equations.
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lethal clinical outcome and immune desert contexture in refractory gastric cancer harboring CCNE1 amplification and overexpression.

British journal of cancer·2026
Same author

Covalent FAPI Imaging-Guided Precision Surgery in Patients with Medullary Thyroid Carcinoma: A Phase II Clinical Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

CD8<sup>+</sup> T Cell Infiltration Elicits Molecular Subtype-Biased Clinical Outcomes in Gastric Cancer Patients.

Cancer science·2026
Same author

Temporal Conditioning for Longitudinal Brain MRI Registration and Aging Analysis.

IEEE transactions on medical imaging·2026
Same author

Large-Scale Validation of a Dual Cross-Attention Network for Automated Sleep Staging Using Wearable Photoplethysmography Signals.

Diagnostics (Basel, Switzerland)·2026
Same author

Poor clinical outcomes and immunoevasive contexture in gastric cancer patients bearing p16 high phenotype.

Cancer·2026

Related Experiment Video

Updated: May 29, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

A gradient Markov chain Monte Carlo algorithm for computing multivariate maximum likelihood estimates and posterior

Ruochen Li1, James D Englehardt, Xiaoguang Li

  • 1Department of Civil, Architectural, and Environmental Engineering, University of Miami, Miami, FL, USA.

Risk Analysis : an Official Publication of the Society for Risk Analysis
|September 13, 2011
PubMed
Summary

A new two-stage computational method using gradient Markov chain Monte Carlo (GMCMC) efficiently estimates multivariate distributions and parameter uncertainty for complex biological data. This approach significantly reduces data requirements for dose-response modeling.

Related Experiment Videos

Last Updated: May 29, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

Area of Science:

  • Computational Statistics
  • Toxicology
  • Biostatistics

Background:

  • Multivariate probability distributions are essential for analyzing complex biological data, such as dose-response relationships, but are often difficult to fit due to high parameterization.
  • Emerging large electronic datasets, including dose-response biomarker and genetic information, necessitate advanced computational methods for effective analysis.
  • Traditional Markov chain Monte Carlo (MCMC) methods can be computationally intensive and require substantial data for convergence.

Purpose of the Study:

  • To introduce a novel two-stage computational approach for estimating multivariate distributions and addressing parameter uncertainty.
  • To improve the efficiency and reduce data requirements for fitting complex dose-response models.
  • To demonstrate the application of the method for conditional and unconditional emergent dose-response functions (DRFs) and mixture toxicity assessments.

Main Methods:

  • A two-stage computational strategy combining gradient Markov chain Monte Carlo (GMCMC) and MCMC simulations.
  • The first stage utilizes GMCMC to obtain Bayesian posterior mode estimates (PMEs) of parameters, serving as efficient starting points.
  • The second stage employs these PMEs to initialize MCMC, enabling convergent simulation of the full posterior distribution and predictive distributions.

Main Results:

  • The proposed method significantly reduces data requirements for dose-response modeling, achieving a 21-fold reduction for conditional DRFs and a 71% reduction for unconditional DRFs.
  • Demonstrated successful application to benzene-toluene mixture data, estimating both common-mode and dissimilar-mode DRFs.
  • Successfully applied to a PCB 126-PCB 153 mixture, showcasing the method's versatility in toxicological assessments.

Conclusions:

  • The novel two-stage GMCMC-MCMC approach provides an efficient and data-saving alternative for estimating complex multivariate distributions and parameter uncertainty.
  • This method enhances the analysis of large biological and toxicological datasets, facilitating more robust dose-response assessments.
  • The provided Matlab(®) programs enable practical implementation of this advanced computational technique.